What findings would be expected on physical examination in a patient with uterine fibroids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physical Examination Findings in Uterine Fibroids

On physical examination of a patient with uterine fibroids, you should expect to find an enlarged, irregularly contoured uterus with firm, non-tender nodular masses palpable on bimanual pelvic examination, often with reduced uterine mobility depending on fibroid size and location 1, 2.

Key Examination Components and Expected Findings

Abdominal Examination

  • Palpable abdominal mass extending from the pelvis when fibroids are large (typically >12-week size)
  • Abdominal distension or visible enlargement, particularly with subserosal or large intramural fibroids 3, 2
  • The mass is typically firm, non-tender, and moves with the uterus

Speculum Examination

  • Generally normal cervical appearance in most cases
  • Occasionally, protruding submucosal fibroids may be visible through the cervical os in advanced cases
  • Assessment for other sources of bleeding (cervical pathology, vaginal lesions)

Bimanual Pelvic Examination

The bimanual examination is the most informative component:

  • Enlarged uterus beyond normal size (normal nulliparous uterus is approximately 7-8 cm length)
  • Irregular, nodular contour rather than smooth uterine surface—this is the hallmark finding that distinguishes fibroids from uniform uterine enlargement 1, 2
  • Firm consistency of palpable masses (fibroids are characteristically firm to hard)
  • Reduced uterine mobility when fibroids are large or when there are multiple fibroids creating a bulky uterus
  • Non-tender on palpation in uncomplicated cases (tenderness suggests degenerating fibroids or other pathology)
  • Asymmetric uterine enlargement depending on fibroid location

Location-Specific Findings

Subserosal fibroids:

  • Palpable as distinct nodular masses on the uterine surface
  • May be pedunculated and mobile
  • Can be confused with adnexal masses if pedunculated 4

Intramural fibroids:

  • Create generalized uterine enlargement with irregular contour
  • Firm, nodular texture throughout the uterine body 5

Submucosal fibroids:

  • May not significantly alter external uterine contour
  • Rarely, large submucosal fibroids may prolapse through the cervix and be visible on speculum exam

Clinical Context and Pitfalls

Important Caveats

Most fibroids are asymptomatic (at least 50% of cases), and physical examination findings do not always correlate with symptom severity 5, 6. The size, number, and location determine clinical behavior more than examination findings alone 5.

Common diagnostic pitfalls to avoid:

  • Pedunculated subserosal fibroids can mimic ovarian masses—reduced mobility with the uterus helps distinguish them 4
  • Adenomyosis presents with diffuse uterine enlargement and tenderness, typically with a softer, more symmetric, "boggy" uterus rather than the firm, irregular nodularity of fibroids 7
  • Early pregnancy must be excluded in reproductive-age women with uterine enlargement
  • Uterine sarcoma cannot be reliably distinguished from fibroids on physical examination alone—rapid growth or postmenopausal presentation warrants heightened suspicion

Patient Demographics Matter

Physical examination findings are influenced by patient characteristics. Black women tend to have larger, more numerous fibroids at diagnosis, making examination findings more pronounced 3. Fibroids are most clinically significant in the perimenopausal years (peak age 30-50 years) and typically regress after menopause 5, 3.

Examination Limitations

Physical examination alone has significant limitations. While it can detect moderate to large fibroids, small fibroids and submucosal fibroids are often not palpable 1, 2. The examination cannot reliably:

  • Determine exact fibroid number, size, or precise location
  • Distinguish fibroids from other pelvic masses definitively
  • Assess cavity distortion or submucosal component

Therefore, imaging confirmation is essential—transvaginal and transabdominal ultrasound combined is the initial imaging modality of choice, with sensitivity of 90-99% for detecting fibroids 3, 2, 8. MRI is reserved for complex cases, preoperative planning, or when ultrasound is inconclusive 3.

References

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Research

Uterine Fibroids: Rapid Evidence Review.

American family physician, 2025

Guideline

acr appropriateness criteria® fibroids.

Journal of the American College of Radiology, 2022

Research

Clinical presentation of fibroids.

Best practice & research. Clinical obstetrics & gynaecology, 2008

Research

Guideline No. 461: The Management of Uterine Fibroids.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.